SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS)
$0 None (None%)
Analysed SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS) News Sources
3 Asian Stocks Estimated To Be Undervalued By Up To 31.5%
04-02-2026
yahoo.com
3 Asian Stocks That Might Be Priced Below Their Estimated Value
03-02-2026
yahoo.com
Global Market Gems 3 Stocks That Could Be Priced Below Fair Value Estimates
03-02-2026
yahoo.com
3 Asian Stocks That May Be Trading Up To 43.8% Below Intrinsic Value Estimates
03-02-2026
yahoo.com
3 Asian Stocks That May Be Trading Below Their Estimated Value
02-02-2026
yahoo.com
3 Asian Stocks Estimated To Be Trading At Discounts Up To 48.2%
28-01-2026
yahoo.com
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease
27-01-2026
yahoo.com
Asian Stocks With Estimated Discounts Up To 44.4% Offering Investment Opportunities
20-01-2026
yahoo.com
Asian Market's Top Value Stocks Estimated Below Intrinsic Worth January 2026
19-01-2026
yahoo.com
3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 48%
09-12-2025
yahoo.com
What is the current price of SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS)?
The current price of SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS) is $0.
SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS) since the previous trading day is $None.
SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS)?
The most recent average sentiment score for SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS) is 67 out of 100.
What is the most recent average sentiment for SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS)?
The most recent sentiment for SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS) is .
SEC-8K** Filing Available For SIMCERE PHARMACEUTICAL GROUP (SMHGF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.